These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12868194)
1. [CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer]. Grotowski M; Wojtuń S Pol Merkur Lekarski; 2003 Apr; 14(82):327-30. PubMed ID: 12868194 [TBL] [Abstract][Full Text] [Related]
2. [Receptors of selected cytokines and angiokine bFGF in patients with colorectal cancer (a preliminary study)]. Grotowski M; Piechota W Pol Merkur Lekarski; 2001 Nov; 11(65):398-401. PubMed ID: 11852807 [TBL] [Abstract][Full Text] [Related]
3. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. Grotowski M; Maruszyński M; Piechota W Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841 [TBL] [Abstract][Full Text] [Related]
4. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469 [TBL] [Abstract][Full Text] [Related]
5. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139 [TBL] [Abstract][Full Text] [Related]
8. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer. Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107 [TBL] [Abstract][Full Text] [Related]
9. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372 [TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Schneider J; Schulze G Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971 [TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer. Gebauer G; Müller-Ruchholtz W Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011 [TBL] [Abstract][Full Text] [Related]
13. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
14. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease? Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Forones NM; Mandowsky SV; Lourenço LG Hepatogastroenterology; 2001; 48(40):1199-201. PubMed ID: 11490833 [TBL] [Abstract][Full Text] [Related]
16. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients. Nakayama T; Watanabe M; Teramoto T; Kitajima M Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502 [TBL] [Abstract][Full Text] [Related]
17. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G; Müller-Ruchholtz W Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569 [TBL] [Abstract][Full Text] [Related]
18. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752 [TBL] [Abstract][Full Text] [Related]
19. [Tissue carcinoembryonic antigen: a screening test for increased cell proliferation?]. Rosandić-Pilas M; Hadzić N; Stavljenić A; Juricić M; Sćukanec-Spoljar M Lijec Vjesn; 1989 Aug; 111(8):249-53. PubMed ID: 2811584 [TBL] [Abstract][Full Text] [Related]
20. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G; Müller-Ruchholtz W Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]